One of the most intriguing questions surrounding HTLV-1-associated diseases is why ATL predominantly develops in geographically restricted endemic regions such as southwestern Japan, despite global human migration.
The classical explanation has focused primarily on viral transmission patterns, particularly mother-to-child transmission through breastfeeding. However, this alone cannot fully explain the striking regional specificity, extremely long latency, and aging-associated emergence of ATL.
Our integrated model suggests that ATL development may require the convergence of multiple long-term biological processes:
・ chronic HTLV-1 persistence,
・ inflammaging,
・ immunosenescence,
・ mitochondrial exhaustion,
・ epigenetic fixation,
・ and geographically shaped host-microbiome-immune interactions.
Recent deep multiomics analyses demonstrated that ethnicity and geography strongly influence immune regulation, microbiome composition, lipid metabolism, biological aging trajectories, and inflammatory pathways.
Importantly, these biological differences were associated with:
・ altered immune signaling,
・ mitochondrial metabolic pathways,
・ bile acid metabolism,
・ chronic inflammatory tone,
・ and aging-associated molecular networks.
Such findings may provide a framework for understanding why HTLV-1-associated carcinogenesis emerges preferentially in specific populations and environments.
In endemic regions of Japan, HTLV-1 infection is typically acquired vertically during infancy, allowing decades-long interaction between the virus and host aging biology.
This prolonged coexistence may progressively reshape immune and metabolic states throughout life, eventually generating a persistent inflammatory-survival network that promotes ATL emergence in elderly individuals.
Thus, ATL may represent a unique human model in which:
transgenerational viral persistence
intersects with
geography-dependent aging biology.